Supplements / medicine · 11 Oct 2026
A mathematical model of copper and zinc reproduced laboratory patterns of amyloid-beta clumping
Source: Mississippi State University / Bulletin of Mathematical Biology
What the research found
Study (mathematical model checked against lab images, not a treatment trial). ScienceDaily carried the Mississippi State University account on 11 October 2026. Shantia Yarahmadian, Yasser Alzahrani, and Vaghawan Prasad Ojha report in the Bulletin of Mathematical Biology (2026; 88(9); doi 10.1007/s11538-026-01732-1). The model simulates how copper and zinc ions may change aggregation of amyloid-beta, a protein that can form plaques studied in Alzheimer's disease. It also explores two hypothetical ways of interfering with that clumping. The authors compared the simulations with atomic force microscopy of protein clusters. Yarahmadian said the equations matched patterns seen in those images and that mathematics does not replace laboratory or clinical research. The release does not report a patient group, a sex split, or an age band, and it does not show that blocking these metals treats Alzheimer's disease. Educational notes. This is not a test and not a supplement instruction.
Read the original at Mississippi State University / Bulletin of Mathematical Biology
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34